Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

609 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Recruiting

A Study of BG-C477 in Participants With Advanced Solid Tumors

NCT06596473

Conditions
Advanced Solid Tumors
Locations
  • City of Hope Phoenix Cancer Center Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale University Yale Cancer Center New Haven, Connecticut, United States
View all 54 locations
View Trial Details
Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions
Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
  • Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
View all 54 locations
View Trial Details
Recruiting

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

NCT06799065

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Cancer Recurrent, +22 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study of JNJ-87890387 for Advanced Solid Tumors

NCT06178614

Conditions
Advanced Solid Tumors, Neoplasms
Locations
  • Start Midwest Grand Rapids, Michigan, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Centre Leon Berard Lyon, France
  • Institut Gustave Roussy Villejuif, France
View Trial Details
Recruiting

A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors

NCT06730750

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
Locations
  • Local Institution - 0007 Los Angeles, California, United States
  • Local Institution - 0017 Grand Rapids, Michigan, United States
  • Local Institution - 0004 Hackensack, New Jersey, United States
  • Local Institution - 0006 Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

NCT06384352

Conditions
Advanced Solid Tumors
Locations
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Sarah Cannon Research Institute (SCRI) at HealthONE Denver, Colorado, United States
  • Yale School of Medicine - Yale Cancer Center - Smilow Cancer Hospital Care Centers - North Haven North Haven, Connecticut, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 21 locations
View Trial Details
Recruiting

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

NCT07266428

Conditions
Advanced Solid Tumors
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States
View Trial Details

Related conditions